Shirley Campbell Selected Research

ADP-Ribosylation Factor 1

3/2016	ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
1/2014	ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shirley Campbell Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2013
3	Neoplasms (Cancer) 01/2017 - 01/2016
1	Atherosclerosis 01/2022
1	Hypoxia (Hypoxemia) 01/2020
1	Triple Negative Breast Neoplasms 03/2016
1	Neoplasm Metastasis (Metastasis) 09/2013

Drug/Important Bio-Agent (IBA)

4	GTP Phosphohydrolases (GTPases)IBA 03/2016 - 09/2013
2	ADP-Ribosylation Factor 1IBA 03/2016 - 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Collagenases (Collagenase)FDA Link 01/2022
1	Heavy MetalsIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Ionic LiquidsIBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 03/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	rat Ybx3 proteinIBA 01/2016
1	Doxycycline (Periostat)FDA LinkGeneric 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Cre recombinaseIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014